MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
PRLD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Prelude Therapeutics (PRLD) Ownership - Who owns Prelude Therapeutics?

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
175 Innovation Boulevard
Phone
+1 302 467-1280
Employees
79
Web
https://www.preludetx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
348.85M
P/E Ratio
N/A
Total Cash
81.55M
Projected Growth
N/A
Total Debt
17.72M
Revenue
16.72M
Risk (Beta)
2.13
Dividend Yield
N/A
Total Cash/Share
1.02
Total Debt/Equity
N/A
Revenue/Share
0.21 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
PRLD
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for PRLD
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
175 Innovation Boulevard
Phone
+1 302 467-1280
Employees
79
Web
https://www.preludetx.com